Lisata Therapeutics (LSTA) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Lisata Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.00M

Latest Revenue (Q)

$70.00K

Main Segment (Y)

Reportable Segment

Lisata Therapeutics Revenue by Period

Lisata Therapeutics Revenue by Year

Date	Revenue	Change
2024-12-31	$1.00M	100.00%
2023-12-31	-	-100.00%
2022-12-31	$121.37M	100.00%
2021-12-31	-	100.00%
2020-12-31	-	100.00%
2019-12-31	-	100.00%
2018-12-31	-	100.00%
2017-12-31	-	-100.00%
2016-12-31	$35.28M	56.90%
2015-12-31	$22.49M	25.36%
2014-12-31	$17.94M	22.29%
2013-12-31	$14.67M	2.36%
2012-12-31	$14.33M	42.58%
2011-12-31	$10.05M	-85.61%
2010-12-31	$69.82M	503.72%
2009-12-31	$11.57M	13743.64%
2008-12-31	$83.54K	-63.94%
2007-12-31	$231.66K	406.66%
2006-12-31	$45.72K	29.67%
2005-12-31	$35.26K	-27.39%
2004-12-31	$48.56K	-24.87%
2003-12-31	$64.63K	-20.55%
2002-12-31	$81.35K	-24.29%
2001-12-31	$107.45K	-79.79%
2000-12-31	$531.76K	4036.90%
1999-12-31	$12.85K	100.00%
1998-12-31	-	100.00%
1997-03-31	-	100.00%
1996-03-31	-	-100.00%
1995-03-25	$21.05M	177.34%
1994-03-27	$7.59M	2132.35%
1993-03-31	$340.00K	-

Lisata Therapeutics generated $1.00M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Lisata Therapeutics Revenue by Quarter

Date	Revenue	Change
2025-06-30	$70.00K	100.00%
2025-03-31	-	-100.00%
2024-12-31	$1.00M	100.00%
2024-09-30	-	100.00%
2024-06-30	-	100.00%
2024-03-31	-	100.00%
2023-12-31	-	100.00%
2023-09-30	-	100.00%
2023-06-30	-	100.00%
2023-03-31	-	-100.00%
2022-12-31	$121.37M	100.00%
2022-09-30	-	100.00%
2022-06-30	-	100.00%
2022-03-31	-	100.00%
2021-12-31	-	100.00%
2021-09-30	-	100.00%
2021-06-30	-	100.00%
2021-03-31	-	100.00%
2020-12-31	-	100.00%
2020-09-30	-	100.00%
2020-06-30	-	100.00%
2020-03-31	-	100.00%
2019-12-31	-	100.00%
2019-09-30	-	100.00%
2019-06-30	-	100.00%
2019-03-31	-	100.00%
2018-12-31	-	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	-100.00%
2017-12-31	$2.00K	100.00%
2017-09-30	-	100.00%
2017-06-30	-	-100.00%
2017-03-31	$7.92M	-22.15%
2016-12-31	$10.18M	9.22%
2016-09-30	$9.32M	12.25%
2016-06-30	$8.30M	10.83%
2016-03-31	$7.49M	-0.93%
2015-12-31	$7.56M	28.38%
2015-09-30	$5.89M	0.37%
2015-06-30	$5.87M	84.95%
2015-03-31	$3.17M	-39.88%
2014-12-31	$5.28M	28.14%
2014-09-30	$4.12M	-8.27%
2014-06-30	$4.49M	10.69%
2014-03-31	$4.06M	-0.56%
2013-12-31	$4.08M	141.32%
2013-09-30	$1.69M	-61.23%
2013-06-30	$4.36M	72.72%
2013-03-31	$2.52M	-8.26%
2012-12-31	$2.75M	-37.95%
2012-09-30	$4.43M	31.49%
2012-06-30	$3.37M	-84.71%
2012-03-31	$22.06M	23.50%
2011-12-31	$17.86M	0.58%
2011-09-30	$17.76M	-3.82%
2011-06-30	$18.46M	-6.01%
2011-03-31	$19.64M	8.48%
2010-12-31	$18.11M	9.89%
2010-09-30	$16.48M	-15.11%
2010-06-30	$19.41M	22.58%
2010-03-31	$15.83M	38.80%
2009-12-31	$11.41M	13309.91%
2009-09-30	$85.07K	169.20%
2009-06-30	$31.60K	-29.99%
2009-03-31	$45.14K	32.48%
2008-12-31	$34.07K	34.95%
2008-09-30	$25.25K	7.31%
2008-06-30	$23.53K	-

Lisata Therapeutics generated $70.00K in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Lisata Therapeutics Revenue Breakdown

Lisata Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24
Reportable Segment	$1.00M

Lisata Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Lisata Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CASI	CASI Pharmaceuticals	$33.88M	$3.41M
CLGN	CollPlant Bio	$10.96M	$98.00K
LSTA	Lisata Therapeutics	$1.00M	$70.00K
XCUR	Exicure	$500.00K	-
KLTO	Klotho Neurosciences	-	-
ENLV	Enlivex Therapeutics	-	-
NCNA	NuCana	-	-
CLSD	Clearside Biomedical	-	-
MTVA	MetaVia	-	-
PASG	Passage Bio	-	-

LSTA Revenue FAQ

What is Lisata Therapeutics’s yearly revenue?

Lisata Therapeutics's yearly revenue for 2024 was $1M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. LSTA's yearly revenue for 2022 was $121.37M, representing an increase of 100.00% compared to 2021.

What is Lisata Therapeutics’s quarterly revenue?

Lisata Therapeutics's quarterly revenue for Q2 2025 was $70K, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). LSTA's quarterly revenue for Q4 2024 was $1M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Lisata Therapeutics’s revenue growth rate?

Lisata Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -99.18%, and for the last 5 years (2020-2024) was 0%.

What are Lisata Therapeutics’s revenue streams?

Lisata Therapeutics's revenue streams in c 24 are Reportable Segment

What is Lisata Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Lisata Therapeutics was Reportable Segment. This segment made a revenue of $1M, representing 100.00% of the company's total revenue.